June 21, 2013
“This finding seems strange to me.” It was a brief correspondence published in April 2012 in The Lancet, one of the world’s most prestigious medical journals, that unleashed a scandal surrounding large-scale domestic clinical studies on Diovan (valsartan), Novartis Pharma’s...read more